Safe Cell and Gene Therapy Combination: Are We There Yet in Arthritis?

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Precision Medicine in Rheumatoid Arthritis: Are We There Yet?

Clinical Rheumatology
MedicineRheumatology
2019English

Assessing the Safety of New Arthritis Drugs: Are We There Yet?

Journal of Rheumatology
RheumatologyAllergyImmunology
2008English

Predicting Delirium: Are We There Yet?

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2017English

Cancer Immunotherapy: Are We There Yet?

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2013English

Clinical Proteomics: Are We There Yet?

Analytical Chemistry
Analytical Chemistry
2003English

Personalized Medicine: Are We There Yet?

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2008English

CML in India: Are We There Yet?

Indian Journal of Hematology and Blood Transfusion
Hematology
2019English

Are We Half-Way There Yet?

Journal of Education for Sustainable Development
2009English

Personalized Cancer Medicine: Are We There Yet?

Oncologist
Cancer ResearchMedicineOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy